Grants for Schools & Universities
1,355 open opportunities. Open federal grants for colleges, universities, and other educational institutions, each with a plain-English eligibility summary, deadline, and award amount.
Geometric Analysis
Due Nov 3, 2026U.S. National Science Foundation · Amount varies
This NSF program funds research in geometric analysis, including differential geometry, geometric group theory, geometric data analysis, and related mathematical topics, plus conferences and travel. Eligibility is described as unrestricted, open to the broad range of NSF-eligible entities (typically universities, nonprofits, and similar research organizations), subject to additional clarifications. No specific award amounts are listed, though conference proposals reference budgets around $50,000. This is a research-focused opportunity; whether a given applicant qualifies depends on standard NSF eligibility, which the notice does not fully spell out here.
ResearchersSchools & universitiesBroad eligibilityTopology
Due Nov 3, 2026U.S. National Science Foundation · Amount varies
This NSF program funds research in topology, including algebraic and geometric topology, homotopy theory, knots, and topological data analysis, plus conferences and travel. Eligibility is described as unrestricted, open to the broad range of NSF-eligible entities (typically universities, nonprofits, and similar research organizations), subject to additional clarifications. No specific award amounts are listed, though conference proposals reference budgets around $50,000. This is a research-focused opportunity; whether a given applicant qualifies depends on standard NSF eligibility, which the notice does not fully detail here.
ResearchersSchools & universitiesBroad eligibilityDeveloping novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Due Nov 5, 2026National Institutes of Health · Amount varies
This NIH R01 grant supports development of novel theory and methods to understand how genetic and non-genetic factors shape complex human traits, using interdisciplinary modeling and large-scale datasets. It is a research grant aimed primarily at universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. No award amounts are specified. Clinical trials are not allowed under this opportunity, and the eligibility list is research-institution oriented rather than open to nonprofits, small businesses, or individuals broadly.
ResearchersSchools & universitiesGovernment / tribalSecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Due Nov 6, 2026National Institutes of Health · Up to $350K
This NIH/NCI R01 grant funds secondary analysis and integration of existing datasets to study cancer risk and related outcomes such as survival and treatment response. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. The award maximum is about $350,000. Eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly, and applicants typically need access to relevant existing data.
ResearchersSchools & universitiesGovernment / tribalAdvanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Due Nov 10, 2026National Institutes of Health · Up to $300K
This NIH/NCI R33 grant funds advanced development and technical validation of emerging technologies for molecular or cellular characterization of cancer and biospecimen handling, where feasibility has been shown but further validation is needed; clinical trials are not allowed. It is a research grant for universities, research institutions, and similar eligible organizations, and foreign organizations and foreign components are eligible. The award maximum is about $300,000. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.
ResearchersSchools & universitiesEarly-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Due Nov 10, 2026National Institutes of Health · Up to $150K
This NIH/NCI R61 grant funds early-stage, proof-of-concept development of innovative technologies for molecular or cellular characterization of cancer and biospecimen handling; clinical trials are not allowed. It is a research grant for universities, research institutions, and similar eligible organizations, and foreign organizations and foreign components are eligible. The award maximum is about $150,000. Eligibility is oriented toward research institutions rather than nonprofits, businesses, or individuals broadly.
ResearchersSchools & universitiesDoW Spinal Cord Injury, Investigator-Initiated Research Award
Due Nov 12, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
Department of War (Defense Health Agency) Spinal Cord Injury Research Program Investigator-Initiated Research Award funding studies that could meaningfully advance spinal cord injury research, patient care, or quality of life, from basic through translational science. Eligibility is listed as unrestricted/open to any entity type subject to clarification in the full notice; an early-career partnership option allows two principal investigators. No award amount is specified. The stated eligibility is broad.
ResearchersSmall businessSchools & universitiesBroad eligibilityDoW Spinal Cord Injury, Clinical Translation Research Award
Due Nov 12, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
Department of War (Defense Health Agency) Spinal Cord Injury Research Program Clinical Translation Research Award funding early-stage clinical research (feasibility, pilot, optimization) to prepare for larger spinal cord injury trials or implementation. Eligibility is listed as unrestricted/open to any entity type subject to clarification in the full notice; applications must name at least two SCI community partners. No award amount is specified. The stated eligibility is broad, but applicants need clinical research capacity and required partnerships.
ResearchersSchools & universitiesBroad eligibilityNCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Due Nov 13, 2026National Institutes of Health · Amount varies
NIH (NCCIH) R01 funding for mid-phase clinical trials of natural products such as botanicals, dietary supplements, and probiotics that already have strong preliminary data. Intended for research institutions able to conduct hypothesis-driven, milestone-based clinical trials; foreign organizations are not eligible. No dollar amount is stated. It will not support efficacy/effectiveness trials or cancer-treatment trials, and requires substantial prior preliminary data, so it is narrow in scope.
ResearchersSchools & universitiesNarrow eligibilityNCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Due Nov 13, 2026National Institutes of Health · Up to $350K
NIH (NCCIH) phased R61/R33 funding for early-phase clinical trials of natural products (botanicals, probiotics, marketed dietary supplements) with a strong scientific rationale. Suited to research institutions running milestone-driven pharmacokinetic and target-engagement studies; foreign organizations are not eligible. The listed maximum is about $350,000. It is narrow research-only work requiring strong preliminary justification, not a fit for individuals or general nonprofits.
ResearchersSchools & universitiesNarrow eligibilityNIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
Due Nov 13, 2026National Institutes of Health · Up to $750K
NIH (NIDA) K12 institutional career-development funding to support mentored research training for clinician-scientists in substance use and substance use disorder research. Intended for institutions that will run a scholar training program; foreign organizations are not eligible and foreign components are not allowed. The listed maximum is about $750,000. This is an institutional training award, not a grant for individuals or general nonprofits.
Schools & universitiesResearchersLarge awardNarrow eligibilityNCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Due Nov 13, 2026National Institutes of Health · Up to $1.1M
NIH (NCCIH) R33 funding for early-phase clinical trials of natural products (botanicals, dietary supplements, probiotics) to confirm target engagement and inform whether further clinical research is warranted. Intended for research institutions; foreign organizations are not eligible. The listed maximum is about $1,050,000. It will not support efficacy or effectiveness trials and requires strong preliminary data, making it narrow research-only funding.
ResearchersSchools & universitiesLarge awardNarrow eligibilityAdvanced Technologies and Instrumentation for the Astronomical Sciences
Due Nov 16, 2026U.S. National Science Foundation · Amount varies
NSF program (ATI) funding the development of new technologies and instrumentation for ground-based astronomy and astrophysics, including high-risk concepts, hardware, and software. Eligibility is described as unrestricted/open to any entity type subject to standard NSF rules, though awards generally go to research institutions and investigators; confirm in the full solicitation. No award amount is specified. Eligibility as stated is broad.
ResearchersSchools & universitiesBroad eligibilityPlasma Physics
Due Nov 16, 2026U.S. National Science Foundation · Amount varies
NSF Plasma Physics program funding research on plasmas across applications from astrophysics to fusion and materials science, generally submitted through the Division of Physics investigator-initiated solicitation. Eligibility is described as unrestricted/open to any entity type subject to standard NSF rules, though awards generally go to research institutions and investigators; confirm in the full solicitation. No award amount is specified. Eligibility as stated is broad.
ResearchersSchools & universitiesBroad eligibilityMajor Research Instrumentation Program
Due Nov 16, 2026U.S. National Science Foundation · $100K–$4M
NSF Major Research Instrumentation program funding the acquisition or development of multi-user research instruments. Eligibility is limited to US institutions of higher education and US not-for-profit, non-degree-granting research organizations with 501(c)(3) status; for-profit firms can participate only as subaward partners and cannot apply directly. Awards range from about $100,000 up to $4,000,000. This is narrowly scoped to research institutions and large in size.
Schools & universities501(c)(3) onlyLarge awardNarrow eligibilityApplied Mathematics
Due Nov 16, 2026U.S. National Science Foundation · Amount varies
NSF Applied Mathematics program funding research in mathematics motivated by problems in science and engineering, from single-investigator to interdisciplinary team projects. Eligibility is described as unrestricted/open to any entity type subject to standard NSF rules, though in practice these awards generally go to research institutions and their investigators; confirm specifics in the full solicitation. No award amount is specified. Eligibility as stated is broad.
ResearchersSchools & universitiesBroad eligibilityAstronomy and Astrophysics Research Grants
Due Nov 16, 2026U.S. National Science Foundation · Amount varies
NSF Astronomy and Astrophysics Research Grants program funding observational, theoretical, laboratory, and archival studies in astronomy and astrophysics, for individual investigators or collaborations. Eligibility is described as unrestricted/open to any entity type subject to standard NSF rules, though awards generally go to research institutions and investigators; confirm in the full solicitation. No award amount is specified. Eligibility as stated is broad.
ResearchersSchools & universitiesBroad eligibilityEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
Due Nov 16, 2026National Institutes of Health · Up to $50K
This NIH small research grant (R03) funds studies of the ethical, legal, and social implications (ELSI) of human genetics and genomics, including normative, legal, economic, philosophical, or historical analyses and collection of preliminary data. It is aimed at research and educational institutions and organizations, including minority-serving institutions and community-based organizations. Awards run up to about $50,000, suited to small single-investigator projects.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreSpecial Program Announcement for Office of Naval Research Research Opportunity: FY27 Communications and Networking Applied Research
Due Nov 16, 2026Office of Naval Research · $250K–$500K
Office of Naval Research Broad Agency Announcement funding applied research on communications and networking technologies for naval operations. Open to academia, industry, and the research community worldwide, including small and large businesses; federal labs and FFRDCs cannot receive awards directly but may team with eligible applicants. Awards range from about $250,000 up to $500,000. Eligibility is broad, with the noted exclusions for certain government and federally funded entities.
ResearchersSmall businessSchools & universitiesLarge award+1 morePrevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Due Nov 17, 2026National Institutes of Health · Amount varies
NIH (NIAAA) phased R61/R33 funding for research on preventing prenatal alcohol exposure and developing interventions for fetal alcohol spectrum disorders. Intended for research institutions and investigators, including minority-serving and tribal colleges; advancement to the R33 phase depends on meeting milestones. No award amount is stated. This is institution-based research funding with priority for clinical-trial applications, not suited to individuals or general nonprofits.
ResearchersSchools & universitiesNarrow eligibility